Leading the way to safer medication
 Crosscheck  Recommender

Avatrombopag

Description

Avatrombopag is an orally active, small molecule thrombopoietin (TPO) receptor agonist that stimulates proliferation and differentiation of megakaryocytes from bone marrow progenitor cells resulting in increased production of platelets. Avatrombopag does not compete with TPO for binding to the TPO receptor and has an additive effect with TPO on platelet production.

Medicine classification

ATC Code
Title
Class
B02BX08
Avatrombopag
B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BX Other systemic hemostatics

Medicines

Drug
Countries

Austria Lithuania Spain United Kingdom United States

Product monographs

Monograph
Type
Country
DOPTELET Film-coated tablet
MPI, US: SPL/PLR
US
DOPTELET Film-coated tablet
MPI, EU: SmPC